CIRB Studies

Below is the current list of studies covered by the CIRB. Participants should refer to ClinicalTrials.gov for general information about clinical trials. Institutions should refer to the Clinical Trials Support Unit (CTSU) website  for enrollment requirements and accrual status information. 

Study documents approved after July 1, 2013 are available to participating institutions for covered studies on the CTSU website. To request documents approved before July 1, 2013, participating institutions can contact the CIRB Helpdesk.

Review CIRB
Study Number Sort descending Network Study Title CIRB
A222302 Alliance Distance-Based Exercise to Preserve Function And Prevent Disability (DEFEND) Cancer Prevention and Control CIRB
A231601CD Alliance Improving Surgical Care and Outcomes In Older Cancer Patients Through Implementation of An Efficient Pre-Surgical Toolkit (OPTI-Surg) Cancer Prevention and Control CIRB
A231602CD Alliance Assessing Financial Difficulty in Patients with Blood Cancers Cancer Prevention and Control CIRB
A231701CD Alliance Increasing Socioeconomically Disadvantaged Patients’ Engagement in Breast Cancer Surgery Decision Making Through a Shared Decision Making Intervention Cancer Prevention and Control CIRB
A231901CD Alliance Improving Patient-Centered Communication in Breast Cancer: A RCT of a Shared Decision Engagement System (SHARES) Cancer Prevention and Control CIRB
A232301CD Alliance AYA Access Study: An Enhanced eHealth and Chat-Bot Enabled Delivery Model for Clinical Genetic Services in Community AYA Cancer Patients Cancer Prevention and Control CIRB
AALL0331 COG Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL): A Phase III Group-Wide Study Pediatric CIRB
AALL03B1 COG Classification of Acute Lymphoblastic Leukemia Pediatric CIRB
AALL03N1 COG Understanding the Ethnic and Racial Differences in Survival in Children with Acute Lymphoblastic Leukemia Pediatric CIRB
AALL0433 COG Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies. A Groupwide Phase III Study Pediatric CIRB